In other countries
The same active substances on other registers, the same brand first.
- MevlyqEuropean Union · YES Pharmaceutical Development Services GmbHSame brand
- MevlyqCroatiaSame brand
- Mevlyq 0,44 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Yes Pharmaceutical Development Services GmbHSame brand
- Eribulina Advanz Pharma 0,44 MG/ML Solución Inyectable EfgSpain · 0,5 mg/ml · solución inyectable · Advanz Pharma LimitedSame form
- Eribulina Baxter 0,44 MG/ML Solucion Inyectable EfgSpain · 1 mg · solución inyectable · Baxter Holding B.V.Same form
- Eribulina Ever Pharma 0,44 MG/ML Solucion Inyectable EfgSpain · 0,44 mg/ml · solución inyectable · Ever Valinject GmbhSame form
- Eribulin STADA 0,44 mg/ml otopina za injekcijuCroatia · otopina za injekciju · Stada d.o.o., Hercegovačka 14, Zagreb, HrvatskaSame form
- Eribulin Accord 0,44 mg/ml otopina za injekcijuCroatia · otopina za injekciju · Accord Healthcare Polska Sp. z o.o., Ul. Tasmowa 7, Mazowieckie, Varšava, PoljskaSame form
- Eribuline Baxter 0,44 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · Baxter Holding B.V.Same form
- Eribuline EVER Pharma 0,44 mg/ml oplossing voor injectieNetherlands · Oplossing voor injectie · EVER Valinject GmbHSame form
- HalavenRomania · 0,44 mg/ml · sol inj. · Eisai Europe LTDSame form
- HalavenSerbia · 0.44mg/mL · rastvor za injekciju · Ewopharma D.O.O. BeogradSame form
- HalavenSerbia · 0.44mg/mL · rastvor za injekciju · Ewopharma D.O.O. BeogradSame form
- Ebunat Solution for Injection 0.5mg/mlSingapore · 0.5 mg/ml · injection, solution · Natco Pharma Asia Pte. LTD.Same form
- Halaven Solution for Injection 0.5mg/mLSingapore · 1.0 mg/vial · injection, solution · Eisai (Singapore) Pte. LTD.Same form
- HalavenBrazil · United Medical LtdaSame substance
- HalixyBrazil · Natcofarma do Brasil LtdaSame substance
- mesilato de eribulinaBrazil · Natcofarma do Brasil LtdaSame substance
- Eribulin Mesylate InjectionCanada · 0.5 MG / ML · Solution · DR Reddy'S Laboratories LTDSame substance
- HalavenCanada · 0.5 MG / ML · Solution · Eisai LimitedSame substance
- Eribulin Mesylate InjectionCanada · 0.5 MG / ML · Solution · Baxter CorporationSame substance
- Eribulin BaxterEuropean Union · Baxter Holding B.V.Same substance
- HalavenEuropean Union · Eisai GmbHSame substance
- HalavenSaudi Arabia · BSP PharmaceuticalsSame substance
- HALAVEN 0.5 mg/mlSaudi Arabia · EisaiSame substance
- Eribulin Mesylate Injection "F.L." 0.5mg/mLTaiwan · 注射劑 · 台耀化學股份有限公司Same substance
- Eribulin MesylateUnited States · 1MG/2ML · solution · Jiangxi Kvvit PharmSame substance
- HalavenUnited States · 1MG/2ML · solution · Eisai INCSame substance
Packs
| Pack | Code | Status |
|---|---|---|
| 0,44 mg/ml - Soluzione iniettabile - Uso endovenoso - Flaconcino (vetro) 2 ml - 1 flaconcino | 051108013 | Autorizzata |
Documents
The official texts, at the regulator.
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog · Added 13 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Eribulin
- Dosage form
- Soluzione iniettabile
- Register
- Italy (AIFA)
- Status
- Authorised
- Status in the register
- Autorizzata
- Registration
- AIC 051108
- Marketing authorisation holder
- Yes Pharmaceutical Development Services GMBH
- ATC code
- L01XX41
- Procedure
- Procedura Centralizzata
- Supply
- Medicinali soggetti a prescrizione medica limitativa, utilizzabili esclusivamente in ambiente ospedaliero o in una struttura ad esso assimilabile